Literature DB >> 33158975

Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia.

Nick P Goplen1,2, Yue Wu3, Young Min Son1, Chaofan Li1, Zheng Wang1, In Su Cheon1, Li Jiang1, Bibo Zhu1, Katayoun Ayasoufi3, Eduardo N Chini2,4, Aaron J Johnson3, Robert Vassallo1, Andrew H Limper1, Nu Zhang5, Jie Sun6,2,3.   

Abstract

Lower respiratory viral infections, such as influenza virus and severe acute respiratory syndrome coronavirus 2 infections, often cause severe viral pneumonia in aged individuals. Here, we report that influenza viral pneumonia leads to chronic nonresolving lung pathology and exacerbated accumulation of CD8+ tissue-resident memory T cells (TRM) in the respiratory tract of aged hosts. TRM cell accumulation relies on elevated TGF-β present in aged tissues. Further, we show that TRM cells isolated from aged lungs lack a subpopulation characterized by expression of molecules involved in TCR signaling and effector function. Consequently, TRM cells from aged lungs were insufficient to provide heterologous protective immunity. The depletion of CD8+ TRM cells dampens persistent chronic lung inflammation and ameliorates tissue fibrosis in aged, but not young, animals. Collectively, our data demonstrate that age-associated TRM cell malfunction supports chronic lung inflammatory and fibrotic sequelae after viral pneumonia.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33158975      PMCID: PMC7970412          DOI: 10.1126/sciimmunol.abc4557

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  73 in total

1.  Cell-intrinsic defects in the proliferative response of antiviral memory CD8 T cells in aged mice upon secondary infection.

Authors:  Vilma Decman; Brian J Laidlaw; Lauren J Dimenna; Sarah Abdulla; Krystyna Mozdzanowska; Jan Erikson; Hildegund C J Ertl; E John Wherry
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

2.  Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection.

Authors:  Tao Wu; Yinghong Hu; Young-Tae Lee; Keith R Bouchard; Alexandre Benechet; Kamal Khanna; Linda S Cauley
Journal:  J Leukoc Biol       Date:  2013-09-04       Impact factor: 4.962

3.  Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity.

Authors:  Bram Slütter; Natalija Van Braeckel-Budimir; Georges Abboud; Steven M Varga; Shahram Salek-Ardakani; John T Harty
Journal:  Sci Immunol       Date:  2017-01-06

4.  Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.

Authors:  André Ballesteros-Tato; Beatriz León; Byung O Lee; Frances E Lund; Troy D Randall
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

5.  Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.

Authors:  Emma Grant; Chao Wu; Kok-Fei Chan; Sidonia Eckle; Mandvi Bharadwaj; Quan Ming Zou; Katherine Kedzierska; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2013-02       Impact factor: 5.126

6.  Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants.

Authors:  Shamus P Keeler; Eugene V Agapov; Michael E Hinojosa; Adam N Letvin; Kangyun Wu; Michael J Holtzman
Journal:  J Immunol       Date:  2018-09-12       Impact factor: 5.422

7.  Comparative analysis reveals a role for TGF-β in shaping the residency-related transcriptional signature in tissue-resident memory CD8+ T cells.

Authors:  Artika P Nath; Asolina Braun; Scott C Ritchie; Francis R Carbone; Laura K Mackay; Thomas Gebhardt; Michael Inouye
Journal:  PLoS One       Date:  2019-02-11       Impact factor: 3.240

8.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

9.  Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+ T cell response magnitude.

Authors:  Kylie M Quinn; Wan-Ting Kan; Katherine A Watson; Brian J Liddicoat; Natasha G Swan; Hayley McQuilten; Alice E Denton; Jasmine Li; Weisan Chen; Lorena E Brown; David C Jackson; Patrick C Reading; Peter C Doherty; Katherine Kedzierska; Lukasz Kedzierski; Stephen J Turner; Nicole L La Gruta
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

10.  Clinical progression of patients with COVID-19 in Shanghai, China.

Authors:  Jun Chen; Tangkai Qi; Li Liu; Yun Ling; Zhiping Qian; Tao Li; Feng Li; Qingnian Xu; Yuyi Zhang; Shuibao Xu; Zhigang Song; Yigang Zeng; Yinzhong Shen; Yuxin Shi; Tongyu Zhu; Hongzhou Lu
Journal:  J Infect       Date:  2020-03-19       Impact factor: 6.072

View more
  32 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

2.  Immune signatures underlying post-acute COVID-19 lung sequelae.

Authors:  I S Cheon; C Li; Y M Son; N P Goplen; Y Wu; T Cassmann; Z Wang; X Wei; J Tang; Y Li; H Marlow; S Hughes; L Hammel; T M Cox; E Goddery; K Ayasoufi; D Weiskopf; J Boonyaratanakornkit; H Dong; H Li; R Chakraborty; A J Johnson; E Edell; J J Taylor; M H Kaplan; A Sette; B J Bartholmai; R Kern; R Vassallo; J Sun
Journal:  Sci Immunol       Date:  2021-11-12

Review 3.  Understanding T cell aging to improve anti-viral immunity.

Authors:  Huimin Zhang; Cornelia M Weyand; Jörg J Goronzy; Claire E Gustafson
Journal:  Curr Opin Virol       Date:  2021-10-21       Impact factor: 7.090

Review 4.  Immune Senescence, Immunosenescence and Aging.

Authors:  Kyoo-A Lee; Rafael R Flores; In Hwa Jang; Ashley Saathoff; Paul D Robbins
Journal:  Front Aging       Date:  2022-05-30

Review 5.  Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity.

Authors:  Rudragouda Channappanavar; Stanley Perlman
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 6.  Tissue-specific immunity for a changing world.

Authors:  Stuart P Weisberg; Basak B Ural; Donna L Farber
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

7.  Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses.

Authors:  Young Min Son; In Su Cheon; Yue Wu; Chaofan Li; Zheng Wang; Xiaochen Gao; Yao Chen; Yoshimasa Takahashi; Yang-Xin Fu; Alexander L Dent; Mark H Kaplan; Justin J Taylor; Weiguo Cui; Jie Sun
Journal:  Sci Immunol       Date:  2021-01-08

Review 8.  TGF-β: Many Paths to CD103+ CD8 T Cell Residency.

Authors:  Zhijuan Qiu; Timothy H Chu; Brian S Sheridan
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

9.  Aging imparts cell-autonomous dysfunction to regulatory T cells during recovery from influenza pneumonia.

Authors:  Luisa Morales-Nebreda; Kathryn A Helmin; Manuel A Torres Acosta; Nikolay S Markov; Jennifer Yuan-Shih Hu; Anthony M Joudi; Raul Piseaux-Aillon; Hiam Abdala-Valencia; Yuliya Politanska; Benjamin D Singer
Journal:  JCI Insight       Date:  2021-03-22

Review 10.  Aging and respiratory viral infection: from acute morbidity to chronic sequelae.

Authors:  Yue Wu; Nick P Goplen; Jie Sun
Journal:  Cell Biosci       Date:  2021-06-22       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.